Portugal, April 15 -- Portugal based Cencora 3PL Portugal, S.A. has secured contract from Instituto Portugues De Oncologia Do Porto Francisco Gentil, Epe for Adcm 4711 2025 - Acquisition Of Tafasitamab 200 Mg Powder Conc Sol Inj Fr Iv. The value of the contract is worth 5614400 EUR.
Published by HT Digital Content Services with permission from Pivotal Sources....